680 results

• Roundup non-Hodgkins Lymphoma Lawsuit Ends in $1.25M Verdict Against Bayer

  October 23, 2023

  Irvin Jackson

  A jury in Missouri wants Bayer to pay $1.25 million in compensatory damages as the result of a Roundup lawsuit by a St. Louis man who says he developed non-Hodgkin's lymphoma after using the weed killer.

• Mirena IUD Class Action Lawsuit Over Breast Cancer Risk Cleared to Move Forward

  October 12, 2023

  Irvin Jackson

  A Mirena breast cancer class action lawsuit is moving forward after a federal judge rejected Bayer's efforts to dismiss the complaint.

• Class Action Lawsuit Filed Over Benzene in Lotramin, Tinactin Spray Products

  September 27, 2023

  Irvin Jackson

  The manufacturers of Lotramin and Tinactin foot sprays face a class action lawsuit from consumers who say the company knew the products contained benzene and continued to sell them illegally.

• Roundup Cancer Trial Ends in Defense Verdict in Missouri Court

  May 25, 2023

  Irvin Jackson

  A Roundup cancer lawsuit has ended in a defense verdict in Missouri state court.

• Roundup Class Action Settlement Objection Will Not Be Considered by U.S. Supreme Court

  May 17, 2023

  Irvin Jackson

  The U.S. Supreme Court has refused to review a decision upholding a $39 million Roundup class action settlement agreement.

• Roundup Jury Trial Over Non-Hodgkin’s Lymphoma Risk Underway in St. Louis

  April 27, 2023

  Irvin Jackson

  A St. Louis County jury has begun hearing a trial over whether Roundup non-Hodgkin's lymphoma risks led to a woman developing cancer.

• Roundup Exposure May Increase Children’s Risk of Liver Disease and Diabetes: Study

  March 16, 2023

  Irvin Jackson

  The findings of a new study like Roundup exposure to an increased risk of diabetes, liver cancer.

• New Study Reinforces Link Between Exposure to Roundup and Cancer Risk

  January 31, 2023

  Irvin Jackson

  Federal researchers say they have linked exposure to Roundup to increased urinary oxidative stress, a known biomarker for increased cancer risks.

• Horizon Therapeutics Acquired for Nearly $30B Amid Growing Threat of Tepezza Lawsuit Payouts

  December 15, 2022

  Irvin Jackson

  Despite the threat of having to eventually pay Tepezza lawsuit payouts, Amgen has acquired the drug's manufacturer, Horizon Pharmaceuticals for nearly $30 billion.

• Roundup May Increase Risk Antibiotic Resistance to Bacterial Infection That Kills Thousands of Americans Every Year: Study

  December 7, 2022

  Irvin Jackson

  The findings of a new study warn that Roundup exposure could lead to the development of antibiotic resistance in dangerous, infection-causing microorganisms.